Bluestem Biosciences, a renewable chemicals company focused on maximizing agriculture and energy infrastructure through leading-edge synthetic biology, announces the filing of 24 patent applications protecting its anaerobic chemical platform with a combined total addressable market of over US $100 billion.

At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals.

Bluestem's patent-pending chemicals platform supports the company's multi-year vision to decarbonize the chemicals industry with affordable bio-based alternatives capable of leveraging current infrastructure. This reimagined chemical platform leverages discovery tools utilizing the latest in digital biology to accelerate commercialization. These advancements unlock cost-competitive anaerobic bio-production, making chemicals from organisms not oil.

"We are excited to take this important step towards decarbonizing the chemical industry," said Billy Hagstrom, CEO, Bluestem Biosciences.

"Our technology has the potential to significantly reduce the carbon footprint of the chemical industry and to provide a sustainable solution for the bio-production of chemicals," added Hagstorm.

Bluestem has announced the Anaerobic Launch Committee with over 150 years of collective experience and domain expertise to facilitate discovery and commercialization: Dr. Gregg Beckham, Senior Research Fellow, NREL; Dr. Hugo Cueto-Rojas, USP Lead Scientist, uniQure biopharma; Dr. B.V. Cathy Asleson Dundon, Biotechnology Consultant, NordYeast Inc.; Kevin Moore, CTO, Biobased Products, Iowa State University; Dr. Darren Platt, Former President & CIO, Demetrix; Dr. Neil Renninger, Co-Founder of Amyris & Ripple Foods; and Dr. John Warner, Founder, Warner Babcock Institute for Green Chemistry.

"The chemical industry is a major contributor to greenhouse gas emissions, and it is essential that we take action to decarbonize this sector at scale," said Neil Renninger, Investor & Advisor to the Anaerobic Launch Committee.

"Bluestem's technology has the potential to make a significant impact through anaerobic bio-production, and we are excited to support Bluestem to accelerate their commercial success," added Renninger.

Bluestem Biosciences, Inc., is designing biology with the end in mind, to enable existing infrastructure in the Midwest. The company is leveraging digital biology to facilitate the discovery of biomanufacturing, focused on the sustainable production of decarbonized bio-chemicals. Founded in 2022 by Billy Hagstrom, Tyler Autera and Jared Wenger; Bluestem will make chemicals from organisms, not oil.